Syneron to Present at the Leerink Swann 2012 Global Healthcare Conference
03 Febrero 2012 - 11:00AM
Marketwired
Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic
device company, announced today that Louis P. Scafuri, Chief
Executive Officer, is scheduled to present at the Leerink Swann
2012 Global Healthcare Conference in New York City.
Conference: Leerink Swann 2012 Global
Healthcare Conference Date: Wednesday,
February 15, 2012 Time: 3:00 p.m. ET
The presentation will be webcast live over the Internet and can
be accessed through the Investor Relations section on Syneron's
website at www.syneron.com. Please go to the website a few minutes
early, as it may be necessary to download audio software to hear
the presentation.
About Syneron Medical Ltd. Syneron Medical
Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company
with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The Company markets, services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide.
Contacts: Asaf Alperovitz Chief Financial Officer + 972
73 244 2283 Email: Email Contact Zack Kubow The Ruth Group
646-536-7020 Email: Email Contact
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Syneron Medical Ltd. - Ordinary Shares (NASDAQ): 0 recent articles
Más de Syneron Medical Ltd. Artículos de Noticias